Dr. Joanne Mortimer discusses functional imaging of HER2-positive metastatic breast cancer using 64Cu DOTA-trastuzumab positron emission tomography (PET).  This technology is being developed at the City of Hope Comprehensive Cancer Center. This interview was filmed at the American Society of Clinical Oncology Annual Meeting in Chicago 2012. Joanne Mortimer, MD, is the Director of the [...]

Dr. Joanne Mortimer discusses clinical highlights from the American Society of Clinical Oncology 2012 annual meeting. This interview was filmed at the American Society of Clinical Oncology Annual Meeting in Chicago 2012. Joanne Mortimer, MD, is the Director of the Women’s Cancers Program at City of Hope Comprehensive Cancer Center in Duarte, California. The Group [...]

Dr. Cliff Hudis discusses clinical trials and tissue collection in breast cancer research. This interview was filmed at the American Society of Clinical Oncology Annual Meeting in Chicago 2012. Clifford A. Hudis, MD is the Chief, Breast Cancer Medicine at Memorial Sloan-Kettering Cancer Center in New York City. He is a medical oncologist with research [...]

Dr. Cliff Hudis discusses paclitaxel beat two newer chemotherapies—nab-paclitaxel (Abraxane) and ixabepilone (Ixempra)—in the treatment of metastatic breast cancer patients who have not had prior systemic therapies. Paclitaxel fared better in terms of both efficacy and safety compared to the newer agents at the designated doses. This interview was filmed at the American Society of [...]

Dr. Cliff Hudis discuss with data from the T-DM1 EMILIA trial for HER-2 Positive Advanced Breast Cancer presented by Dr. Kimberly Blackwell at ASCO 2012. This interview was filmed at the American Society of Clinical Oncology Annual Meeting in Chicago 2012. Clifford A. Hudis, MD is the Chief, Breast Cancer Medicine at Memorial Sloan-Kettering Cancer [...]

Advocacy in Action sat down with Ginny Mason to learn more about the Inflammatory Breast Cancer Research Foundation and the work they do to help those with inflammatory breast cancer through both education and research. Advocacy in Action videos at the American Association for Cancer Research (AACR) Annual Meeting 2012 was made possible, in part, [...]

Ginny Mason, RN, Executive Director of the Inflammatory Breast Cancer Research Foundation, gives an overview of inflammatory breast cancer (IBC) symptoms, how it presents, as well as treatment options. Advocacy in Action videos at the American Association for Cancer Research (AACR) Annual Meeting 2012 was made possible, in part, by: VIDEO TRANSCRIPT Selma Schimmel, Founder [...]

Dr. Jose Baselga gives an Pi3 Kinase Inhibitor update  for breast cancer patients at the American Association for Cancer Research (AACR) Annual 2012 meeting in Chicago. Jose Baselga, MD, PhD is the Chief of the Division of Hematology/Oncology, Associate Director of the Massachusetts General Hospital Cancer Center and a Professor, Department of Medicine, Harvard Medical [...]

Dr. Pamela Goodwin discusses the current findings in her ongoing clinical trial looking at the use of metformin (a generic diabetes drug) in patients with breast cancer at the American Association for Cancer Research (AACR) Annual 2012 meeting in Chicago. Pamela Goodwin, MD is a Senior Investigator at the Samuel Lunenfeld Research Institute, Mount Sinai [...]

Dr. Jeffrey Weitzel discusses the BRCA mutation and cancer genetics at the American Association for Cancer Research (AACR) Annual 2012 meeting in Chicago. Jeffrey Weitzel, M.D. is Chief of the Division of Clinical Cancer Genetics at City of Hope. Dr.Weitzel’s multidisciplinary clinical and research program emphasizes the recognition and assessment of people at increased risk [...]